记忆剂使用和亨廷顿病的认知衰退:一个注册的HD研究
Amy C Ogilvie1,2, Jordan L Schultz2,3,4
1Department of Epidemiology The College of Public Health at the University of Iowa Iowa City IA USA.
Movement disorders clinical practice
|July 21, 2023
概括
孟坦丁对亨廷顿病 (HD) 患者没有显著的认知益处. 这项研究发现,在明显的HD患者中,记忆剂使用者和非使用者之间的认知衰退轨迹没有差异.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 孟曼丁是一种NMDA受体对抗剂,已被批准用于阿尔茨海默氏症痴呆症.
- 它在亨廷顿病 (HD) 中的潜在益处已被建议,但尚未广泛研究.
研究的目的:
- 评估孟坦丁在减轻明显亨廷顿病患者认知衰退方面的疗效.
- 分析记忆素对HD患者认知轨迹的影响.
主要方法:
- 利用Enroll-HD研究的数据进行5年认知轨迹分析.
- 雇员倾向-得分匹配,以比较使用者和非使用者关于人口统计和疾病进展.
- 应用线性混合效应模型来评估认知结果.
主要成果:
- 在记忆剂使用者和非使用者之间的认知衰退轨迹中没有观察到统计学上显著的差异.
- 主要结局测量没有显示任何与明确的HD中使用孟坦因相关的益处.
结论:
- 孟坦丁治疗对于明显亨廷顿病患者没有显示出临床益处.
- 建议进行进一步的研究,以探索记忆素对HD临床结果的影响.
更多相关视频
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
158
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
158
Alzheimer's Disease: Treatment
219
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
219
Alzheimer's Disease: Overview
525
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
525
Parkinson's Disease: Treatment
301
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
301
Dementia
141
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
141
Long-term Depression
2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.6K


